diabetes mellitus, type 2
Showing NaN - NaN of 73
Diabetes, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart, insulin glargine, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- +3 more
-
Ebreichsdorf, Austria
- +53 more
Jan 5, 2017
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart, biphasic human insulin)
Completed
- Diabetes
- +2 more
- biphasic insulin aspart
- biphasic human insulin
-
Graz, Austria
- +36 more
Jan 3, 2017
Diabetes, Type 2 Trial in Worldwide (Canagliflozin, 100 mg, Canagliflozin, 300 mg, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin, 100 mg
- +2 more
-
Montgomery, Alabama
- +56 more
Oct 28, 2016
Diabetes, Type 2 Trial in Czech Republic, Germany, Romania (TANTALUS System)
Terminated
- Diabetes Mellitus, Type 2
- TANTALUS System
-
Brno, Czech Republic
- +12 more
Sep 21, 2016
Diabetes, Type 2 Trial in Worldwide (BI 10773, BI 10773 Placebo, BI 10773 / BI 1356)
Completed
- Diabetes Mellitus, Type 2
- BI 10773
- +3 more
-
Chino, California
- +113 more
Mar 4, 2016
Diabetes, Type 2 Trial in Worldwide (Insulin Glargine (Lantus®), Inhaled Human Insulin (Exubera®))
Completed
- Diabetes Mellitus, Type 2
- Insulin Glargine (Lantus®)
- Inhaled Human Insulin (Exubera®)
-
Bornem, Belgium
- +61 more
Jun 30, 2015
Diabetes, Type 2 Trial in Worldwide (LY2189265, Sitagliptin, Placebo solution)
Diabetes, Type 2 Trial in Worldwide (Exenatide (AC2993), Insulin glargine)
Completed
- Diabetes Mellitus, Type 2
- Exenatide (AC2993)
- Insulin glargine
-
San Diego, California
- +90 more
Mar 19, 2015
Diabetes, Type 2 Trial in Worldwide (exenatide, biphasic insulin aspart)
Completed
- Diabetes Mellitus, Type 2
- exenatide
- biphasic insulin aspart
-
Osijek, Croatia
- +68 more
Mar 19, 2015
Diabetes, Type 2 Trial in Worldwide (LY2963016, Lantus, OAMs)
Diabetes, Type 2 Trial in Worldwide (metformin , linagliptin , metformin)
Completed
- Diabetes Mellitus, Type 2
- metformin placebo
- +3 more
-
Dhaka, Bangladesh
- +89 more
Nov 13, 2014
Diabetes, Type 2 Trial in Worldwide (Pioglitazone 15 mg, Pioglitazone 45 mg, Pioglitazone 30 mg)
Completed
- Diabetes Mellitus, Type 2
- Pioglitazone 15 mg
- +6 more
-
Birmingham, Alabama
- +131 more
Oct 9, 2014
Diabetes, Type 2, Diabetes, Endocrine System Diseases Trial in Worldwide (JNJ16269110, Placebo, Metformin)
Completed
- Diabetes Mellitus, Type 2
- +3 more
- JNJ16269110
- +3 more
-
Edegem, Belgium
- +62 more
Jul 10, 2014
Diabetes, Type 2 Trial in Worldwide (BI 10773, , metformin)
Completed
- Diabetes Mellitus, Type 2
- BI 10773
- +2 more
-
Capital Federal, Argentina
- +73 more
May 16, 2014
Diabetes, Type 2 Trial in Worldwide (BI 10773, Metformin, Sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- BI 10773
- +2 more
-
Mission Viejo, California
- +136 more
May 16, 2014
Diabetes, Type 2 Trial in Worldwide (BI 10773, , sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- BI 10773
- +2 more
-
Chula Vista, California
- +115 more
May 16, 2014
Diabetes, Type 2 Trial in Worldwide (Placebo identical to BI 1356 5mg, Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4
Completed
- Diabetes Mellitus, Type 2
- Placebo identical to BI 1356 5mg
- +3 more
-
Tempe, Arizona
- +220 more
Dec 11, 2013
Diabetes, Type 2 Trial in Worldwide (Canakinumab, Metformin, Placebo)
Diabetes, Type 2 Trial in Worldwide (LY2428757, Placebo)
Completed
- Diabetes Mellitus, Type 2
- LY2428757
- Placebo
-
Bermuda Dunes, California
- +59 more
Jul 12, 2011
Diabetes, Type 2 Trial in Worldwide (Insulin Glargine, Insulin Lispro Protamine Suspension (ILPS), Insulin Lispro)
Completed
- Diabetes Mellitus, Type 2
- Insulin Glargine
- +2 more
-
Genk, Belgium
- +49 more
May 11, 2011
Diabetes, Type 2 Trial in Worldwide (Placebo, PF-00734200 10 mg QD, PF-00734200 20 mg QD)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- +4 more
-
Birmingham, Alabama
- +78 more
Jun 22, 2010